Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emdogain in root coverage surgery
NCT03059966Phase 4Completed
- Sponsor
- Universidade Estadual do Rio de Janeiro
- Start
- Mar 2014
- Primary completion
- Dec 2016
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 4, randomised trial in gingival recession comparing Emdogain with Placebo (2 arms). Primary endpoints: Post-surgical pain at 7 days, Root Coverage Score at 180 days and 2 more. Started Mar 2014; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
gingival recession
Beyond the preview
Go deeper on NCT03059966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059966.